FDA Warning Letter — Sewaren Innovative Pharmaceutical Packaging

Case 513186 — FEI 3012292690

The FDA took a Warning Letter action against Sewaren Innovative Pharmaceutical Packaging on May 22, 2017 (Avenel, NJ). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action details

Facility
Sewaren Innovative Pharmaceutical Packaging
Date
May 22, 2017
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
Avenel, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.